Depresszió: vizsgálatok itt: Horvátország

3 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.

• 3. fázisTaking people
  Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

  Where

  Grad Zagreb

  Életkor

  18 év and over

  People

  850 worldwide

  Run by

  Neurocrine Biosciences

  See details and how to joinNCT06966401 · EU 2024-519423-24-00
• 3. fázisTaking people
  Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

  Where

  Grad Zagreb

  Életkor

  18 év and over

  People

  200 worldwide

  Run by

  Neurocrine Biosciences

  See details and how to joinNCT06786624 · EU 2024-519418-29-00
• No phaseTaking people
  Metabolic Profiling of Esketamine Treatment in Depressive Disorder

  Where

  Zagreb

  Életkor

  18 év to 70 év

  People

  100

  Run by

  University of Zagreb

  See details and how to joinNCT07002684